- Biochemical recurrence of prostate cancer detection: 68Ga - PMSA and 18F- fluciclovin in real-life practice2022 | First Faculty of Medicine
- Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer2018 | First Faculty of Medicine, Second Faculty of Medicine
- Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer2020 | Second Faculty of Medicine
- The WNT/beta-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro2019 | Second Faculty of Medicine